Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
ARWR
— Arrowhead Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
FEB 5, 2026
REVENUE
$264.0M
+2.9%
NET MARGIN
11.7%
+20.9 PTS
EPS
$0.22
+229.4%
FREE CASH FLOW
$11.3M
-12.8%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →